• By ICR Secretariat
  • Posted Thursday, April 21, 2022

ISA Pharmaceuticals announce new trial testing technology for cancers

https://www.pharmatimes.com/news/isa_pharmaceuticals_announce_new_trial_testing_technology_for_cancers_1399340

Trial of Amplivant will begin in a number of cancer patients including those with ovarian cancer